Thomas G. Graeber
Impact in
- Cancer Research top 0.2%
- Cancer, Hypoxia, and Metabolism
- Oncology top 0.1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Cancer, Hypoxia, and Metabolism 20
- Cancer Genomics and Diagnostics 8
- Oncology 44
- Cancer-related Molecular Pathways 10
- CAR-T cell therapy research 7
- Co-authors
- Amato J. Giaccia (9 shared papers)Antoni Ribas (26 shared papers)Scott Lowe (1 shared paper)Cameron J. Koch (1 shared paper)David E. Housman (1 shared paper)Tyler Jacks (1 shared paper)Daniel Braas (15 shared papers)Lídia Robert (10 shared papers)
- Journals
- Proceedings of the National Academy of Sciences (12 papers)Cancer Cell (9 papers)Cell Reports (8 papers)Cancer Research (7 papers)Nature (6 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Thomas G. Graeber
153 papers receiving 26.7k citations
Thomas G. Graeber's Hit Papers
Peers
Comparison fields: 5 of 175
- Cancer Research 5.5k
- Oncology 9.4k
- Immunology 6.1k
- Molecular Biology 12.6k
- Genetics 1.5k
Countries citing papers authored by Thomas G. Graeber
This map shows the geographic impact of Thomas G. Graeber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas G. Graeber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas G. Graeber more than expected).
Fields of papers citing papers by Thomas G. Graeber
This network shows the impact of papers produced by Thomas G. Graeber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas G. Graeber. The network helps show where Thomas G. Graeber may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas G. Graeber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 155 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma Hit paper breakdown → | 2016 | 2610 |
| 2 | Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases Hit paper breakdown → | 2019 | 2297 |
| 3 | Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours Hit paper breakdown → | 1996 | 2039 |
| 4 | Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression Hit paper breakdown → | 2017 | 1513 |
| 5 | RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E) Hit paper breakdown → | 2011 | 1203 |
| 6 | Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations Hit paper breakdown → | 2016 | 1098 |
| 7 | An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells Hit paper breakdown → | 2013 | 977 |
| 8 | Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress Hit paper breakdown → | 2018 | 683 |
| 9 | Myc-driven murine prostate cancer shares molecular features with human prostate tumors Hit paper breakdown → | 2003 | 646 |
| 10 | 1994 | 532 | |
| 11 | Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF V600E melanoma Hit paper breakdown → | 2015 | 488 |
| 12 | Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma Hit paper breakdown → | 2014 | 484 |
| 13 | Sterol regulatory element–binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity Hit paper breakdown → | 2013 | 458 |
| 14 | 2011 | 434 | |
| 15 | 2016 | 418 | |
| 16 | 2005 | 348 | |
| 17 | 2010 | 339 | |
| 18 | 2013 | 333 | |
| 19 | 2017 | 321 | |
| 20 | 2014 | 314 |
About Thomas G. Graeber
Thomas G. Graeber is a scholar working on Cancer Research, Oncology, Molecular Biology, Immunology and Pulmonary and Respiratory Medicine, having authored 155 papers that have together received 27.1k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (20 papers), Melanoma and MAPK Pathways (16 papers), Cancer-related Molecular Pathways (10 papers), Cancer Genomics and Diagnostics (8 papers), Advanced Proteomics Techniques and Applications (7 papers), CAR-T cell therapy research (7 papers), RNA modifications and cancer (7 papers) and Immune Response and Inflammation (7 papers). The work is most often cited by research in Cancer Research (5.5k citations), Oncology (9.4k citations), Immunology (6.1k citations), Molecular Biology (12.6k citations) and Genetics (1.5k citations). Thomas G. Graeber has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Amato J. Giaccia, Antoni Ribas, Scott Lowe, Cameron J. Koch, David E. Housman, Tyler Jacks, Daniel Braas, Lídia Robert, Begoña Comı́n-Anduix and Jennifer Tsoi. Their work appears in journals such as Proceedings of the National Academy of Sciences, Cancer Cell, Cell Reports, Cancer Research and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.